GLX351322

CAS No. 835598-94-2

GLX351322( —— )

Catalog No. M21200 CAS No. 835598-94-2

GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 38 Get Quote
5MG 61 Get Quote
10MG 101 Get Quote
25MG 230 Get Quote
50MG 392 Get Quote
100MG 582 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GLX351322
  • Note
    Research use only, not for human use.
  • Brief Description
    GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
  • Description
    GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
  • In Vitro
    GLX351322 is an inhibitor of NADPH oxidase 4, and inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 μM. GLX351322 shows weak activity against NOX2 in hPBMC cells (IC50, 40 μM).
  • In Vivo
    GLX351322 (3.8 mg/kg/day, p.o.) ameliorates HFD-induced hyperglycemia in mice.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NADPH
  • Recptor
    NOX4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    835598-94-2
  • Formula Weight
    431.5
  • Molecular Formula
    C21H25N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:20 mg/mL (46.35 mM; Need ultrasonic)
  • SMILES
    CCOC(=O)c1c(NC(=O)CN2CCN(C(=O)c3ccco3)CC2)sc2c1CCC2
  • Chemical Name
    Ethyl 2-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]acetyl]amino]-56-dihydro-4H-cyclopenta-[b]thiophene-3-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Anvari Ebrahim Wikstr?m Per Walum Eriket al. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice[J]. Free Radical Research 49(11):1-32.
molnova catalog
related products
  • Acetohexamide

    Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2.

  • gp91 ds-tat

    gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.

  • NoxA1ds

    Potent and selective NADPH oxidase 1 (NOX1) inhibitor (IC50 = 20 nM). Exhibits selectivity for NOX1 over NOX2, NOX4, NOX5 and xanthine oxidase. Inhibits NOX1-derived O2- production in HT-29 human colon cancer cells. Attenuates VEGF-induced human pulmonary artery endothelial cell migration under hypoxic conditions in vitro. Cell permeable.